Clinical characteristics and molecular epidemiology of Streptococcus agalactiae infection in non-pregnant adults

doi:10.3969/j.issn.1673-8640.2022.08.017

Abstract

Abstract:

Streptococcus agalactiae has known as the leading cause of invasive disease in neonates and pregnant women. However,the morbidity of Streptococcus agalactiae infection in non-pregnant adults is increasing rapidly. The clinical characteristics of Streptococcus agalactiae infection and the molecular epidemiology of Streptococcus agalactiae isolated from non-pregnant adults have rare understood. The review provides a reference for the diagnosis,treatment prevention and control of this disease.

Key words: Streptococcus agalactiae, Non-pregnant adult, Clinical characteristic, Molecular epidemiology, Capsular polysaccharide serotype, Multiple locus sequence typing

CLC Number:

R446.1

LIU Jingxian, CHEN Xingyue, ZHAO Jing, LIU Ying. Clinical characteristics and molecular epidemiology of Streptococcus agalactiae infection in non-pregnant adults[J]. Laboratory Medicine, 2022, 37(8): 793-797.

References 40

[1]	RUSSELL N J, SEALE A C, O'DRISCOLL M, et al. Maternal colonization with group B Streptococcus and serotype distribution worldwide:systematic review and meta-analyses[J]. Clin Infect Dis, 2017, 65(Suppl 2):S100-S111. DOI URL
[2]	FRANCOIS WATKINS L K, MCGEE L, SCHRAG S J, et al. Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States,2008-2016[J]. JAMA Intern Med, 2019, 179(4):479-488. DOI URL
[3]	GRAUX E, HITES M, MARTINY D, et al. Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region,2005-2019[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(3):515-523. DOI URL
[4]	ABDELRADI A, MURPHY A, AHASIC A M. Invasive Streptococcus agalactiae causing meningitis,ventriculitis,and endocarditis in a non-pregnant adult[J]. Cureus, 2020, 12(11):e11412.
[5]	CRUM-CIANFLONE N F. An unusual case of a large,sporadic intra-abdominal abscess due to group B Streptococcus and a review of the literature[J]. Infection, 2015, 43(2):223-227. DOI URL
[6]	SUNKARA B, BHEEMREDDY S, LORBER B, et al. Group B Streptococcus infections in non-pregnant adults:the role of immunosuppression[J]. Int J Infect Dis, 2012, 16(3):e182-e186.
[7]	LEE N Y, YAN J J, WU J J, et al. Group B streptococcal soft tissue infections in non-pregnant adults[J]. Clin Microbiol Infect, 2005, 11(7):577-579. DOI URL
[8]	VUILLEMIN X, HAYS C, PLAINVERT C, et al. Invasive group B Streptococcus infections in non-pregnant adults:a retrospective study,France,2007-2019[J]. Clin Microbiol Infect, 2021, 27(1):129.e1-129.e4.
[9]	HO C M, CHI C Y, HO M W, et al. Clinical characteristics of group B streptococcus bacteremia in non-pregnant adults[J]. J Microbiol Immunol Infect, 2006, 39(5):396-401.
[10]	ALIZZI M, RATHNAYAKE R, SIVABALAN P, et al. Group B streptococcal bacteraemia-changing trends in a tropical region of Australia[J]. Intern Med J, 2022, 52(5):800-807. DOI URL
[11]	CHO S Y, KANG C I, KIM J, et al. Association of liver cirrhosis with group B streptococcal bacteremia in non-pregnant adults[J]. J Infect, 2013, 67(6):617-619. DOI URL
[12]	BENMIMOUN B, PAPASTEFANAKI F, PÉRICHON B, et al. An original infection model identifies host lipoprotein import as a route for blood-brain barrier crossing[J]. Nat Commun, 2020, 11(1):6106. DOI URL
[13]	PAYUS A O, CLARENCE C, AZMAN ALI R. Group B streptococcal meningitis in a healthy young woman:a case report[J]. Int J Gen Med, 2020, 13:861-864. DOI URL
[14]	HIRAI J, KINJO T, HARANAGA S, et al. A case report of cerebral meningitis caused by penicillin-non-susceptible group B Streptococcus in an immunocompromised adult patient[J]. Infect Drug Resist, 2020, 13:2155-2160. DOI URL
[15]	YOSHIDA M, YOKOKURA S, NISHIDA T, et al. Endogenous endophthalmitis caused by group B streptococcus;case reports and review of 35 reported cases[J]. BMC Ophthalmol, 2020, 20(1):126. DOI URL
[16]	TCHANA-SATO V, HANS G, FRIPPIAT F, et al. Streptococcus agalactiae infective endocarditis:analysis of eight surgical cases from a single centre[J]. Infect Dis(Lond), 2021, 53(3):189-195.
[17]	LOUBET P, KOUMAR Y, LECHICHE C, et al. Clinical features and outcome of Streptococcus agalactiae bone and joint infections over a 6-year period in a French university hospital[J]. PLoS One, 2021, 16(3):e0248231.
[18]	SENDI P, CHRISTENSSON B, UÇKAY I, et al. Group B streptococcus in prosthetic hip and knee joint-associated infections[J]. J Hosp Infect, 2011, 79(1):64-69. DOI URL
[19]	COLLIN S M, SHETTY N, GUY R, et al. Group B Streptococcus in surgical site and non-invasive bacterial infections worldwide:a systematic review and meta-analysis[J]. Int J Infect Dis, 2019, 83:116-129. DOI URL
[20]	JOHN P P, BAKER B C, PAUDEL S, et al. Exposure to moderate glycosuria induces virulence of group B Streptococcus[J]. J Infect Dis, 2021, 223(5):843-847. DOI URL
[21]	SHING S R, RAMOS A R, PATRAS K A, et al. The fungal pathogen Candida albicans promotes bladder colonization of group B Streptococcus[J]. Front Cell Infect Microbiol, 2020, 9:437. DOI URL
[22]	SLOTYED H C, KONG F, LAMBERTSEN L, et al. Serotype Ⅸ,a proposed new Streptococcus agalactiae serotype[J]. J ClinMicrobiol, 2007, 45(9):2929-2936.
[23]	FURFARO L L, CHANG B J, PAYNE M S. Perinatal Streptococcus agalactiae epidemiology and surveillance targets[J]. ClinMicrobiol Rev, 2018, 31(4):e00049-18.
[24]	BARSHAK M B. Group B Streptococcus,an a-list pathogen in nonpregnant adults[J]. JAMA Intern Med, 2019, 179(4):488-489. DOI URL
[25]	BJÖRNSDÓTTIR E S, MARTINS E R, ERLENDSDÓTTIR H, et al. Changing epidemiology of group B streptococcal infections among adults in Iceland:1975-2014[J]. Clin Microbiol Infect, 2016, 22(4):379.e9-379.e16. DOI URL
[26]	VIGLIAROLO L, ARIAS B, SUÁREZ M, et al. Argentinian multicenter study on urinary tract infections due to Streptococcus agalactiae in adult patients[J]. J Infect Dev Ctries, 2019, 13(1):77-82. DOI URL
[27]	TSAI M H, HSU J F, LAI M Y, et al. Molecular characteristics and antimicrobial resistance of group B streptococcus strains causing invasive disease in neonates and adults[J]. Front Microbiol, 2019, 10:264. DOI URL
[28]	KARDOS S, TÓTHPÁL A, LAUB K, et al. High prevalence of group B streptococcus ST17 hypervirulent clone among non-pregnant patients from a Hungarian venereology clinic[J]. BMC Infect Dis, 2019, 19(1):1009. DOI URL
[29]	DE FIGUEIREDO SANCHES G, LANNES-COSTA P S, CRISTOFORÊTO M C, et al. Streptococcus agalactiae strains isolated from cancer patients in Rio de Janeiro,Brazil[J]. Braz J Microbiol, 2021, 52(1):303-310. DOI URL
[30]	FAVERO L M, CHIDEROLI R T, FERRARI N A, et al. In silico prediction of new drug candidates against the multidrug-resistant and potentially zoonotic fish pathogen serotype Ⅲ Streptococcus agalactiae[J]. Front Genet, 2020, 11:1024. DOI URL
[31]	BARKHAM T, ZADOKS R N, AZMAI M N A, et al. One hypervirulent clone,sequence type 283,accounts for a large proportion of invasive Streptococcus agalactiae isolated from humans and diseased tilapia in Southeast Asia[J]. PLoS Negl Trop Dis, 2019, 13(6):e0007421.
[32]	OMURA Y, KUSAMA Y, TAKEUCHI N, et al. Mediastinal,subcutaneous and multiple muscular abscesses caused by group B streptococcus serotype Ⅷ in a type 2 diabetes mellitus patient[J]. J Infect Chemother, 2018, 24(5):401-403. DOI URL
[33]	HIRAI N, KASAHARA K, UNO K, et al. Infective endocarditis complicated by intraventricular abscesses,pericarditis,and mycotic aneurysm due to an emerging strain of serotype Ⅵ Streptococcus agalactiae[J]. Jpn J Infect Dis, 2017, 70(6):685-686. DOI URL
[34]	TAZI A, MORAND P C, RÉGLIER-POUPET H, et al. Invasive group B streptococcal infections in adults,France(2007-2010)[J]. Clin Microbiol Infect,2011, 17(10):1587-1589. DOI URL
[35]	NIE S, LU X, JIN Z, et al. Characterization of group B Streptococcus isolated from sterile and non-sterile specimens in China[J]. Diagn Microbiol Infect Dis, 2018, 92(1):56-61. DOI URL
[36]	MAEDA T, TAKAYAMA Y, FUJITA T, et al. Comparison between invasive and non-invasive Streptococcus agalactiae isolates from human adults,based on virulence gene profiles,capsular genotypes,sequence types,and antimicrobial resistance patterns[J]. Jpn J Infect Dis, 2021, 74(4):316-324. DOI URL
[37]	PHOOMPOUNG P, PIROGARD N, LEELAPORN A, et al. Incidence of invasive Group B Streptococcus(iGBS)infections and the factors associated with iGBS mortality in adults during 2013-2017:a retrospective study at Thailand's largest national tertiary referral center[J]. Ann Med, 2021, 53(1):715-721. DOI URL
[38]	GUO Y, DENG X, LIANG Y, et al. The draft genomes and investigation of serotype distribution,antimicrobial resistance of group B Streptococcus strains isolated from urine in Suzhou,China[J]. Ann Clin Microbiol Antimicrob, 2018, 17(1):28. DOI URL
[39]	NISHIYAMA N, KINJO T, UECHI K, et al. Clinical and bacterial features of Group B streptococci with reduced penicillin susceptibility from respiratory specimens:a case-control study[J]. Eur J Clin Microbiol Infect Dis, 2021, 41(1):1-8. DOI URL
[40]	MUDZANA R, MAVENYENGWA R T, GUDZA-MUGABE M. Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples[J]. BMC Infect Dis, 2021, 21(1):125. DOI URL